Cardiff Oncology Inc (CRDF)

Oct 21, 2026

FDA gives a drug for a rare blood cancer special status that may bring trial tax credits. - Stock Titan

Oct 21, 2026

Oct 17, 2026

CRDF S-8 & SEC Filings - Yahoo Finance Australia

Oct 17, 2026

Oct 17, 2026

CRDF 8-K & SEC Filings - Yahoo Finance Australia

Oct 17, 2026

Apr 03, 2026

Verastem, Inc. (VSTM) stock price, news, quote and history - Yahoo Finance Singapore

Apr 03, 2026

Oct 05, 2026

Is Cardiff Oncology (NASDAQ:CRDF) Building a More Durable Market Story? - Kalkine Media

Oct 05, 2026

Sep 29, 2026

Verastem, Inc. (VSTM) stock price, news, quote and history - au.finance.yahoo.com

Sep 29, 2026

Sep 21, 2026

Cardiff Oncology (Nasdaq:CRDF)Stock Analysis - Simply Wall Street

Sep 21, 2026

Sep 15, 2026

Let's uncover which stocks are experiencing notable gaps during today's session. - ChartMill

Sep 15, 2026

Sep 14, 2026

Form 8K Cardiff Oncology Inc For: 14 September By Investing.com - Investing.com Canada

Sep 14, 2026

Sep 14, 2026

Form 8K Cardiff Oncology Inc For: 14 September By Investing.com - Investing.com UK

Sep 14, 2026

Sep 14, 2026

Cardiff Oncology settles dispute with NMS over onvansertib rights By Investing.com - Investing.com UK

Sep 14, 2026

Sep 14, 2026

Form 8K Cardiff Oncology Inc For: 14 September By Investing.com - Investing.com India

Sep 14, 2026

Sep 10, 2026

Cardiff Oncology, Inc. (CRDF) Presents at 8th Annual RAS-Targeted Drug Development SummitSlideshow - Seeking Alpha

Sep 10, 2026

Sep 02, 2026

Cardiff Oncology (CRDF) Slips to $1.02 as Biotech Stock Holds Above Key SupportNarrow Range Breakout - dars.gov.et

Sep 02, 2026

Sep 02, 2026

Cardiff Oncology Announces Upcoming Conference Participation for Mani Mohindru, Ph.D. - Quiver Quantitative

Sep 02, 2026

Sep 02, 2026

Cardiff Oncology to Participate in September 2026 Conferences - GlobeNewswire

Sep 02, 2026

Sep 02, 2026

Cardiff Oncology will take part in two September cancer conferences - Stock Titan

Sep 02, 2026

Aug 28, 2026

Cardiff Oncology Inc. (CRDF) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Aug 28, 2026

Aug 27, 2026

Cardiff Oncology Inc. (CRDF) Key Financial Ratios – Valuation, Profitability & More - Value Research

Aug 27, 2026

Aug 26, 2026

Cardiff Oncology (NASDAQ: CRDF) seeks share boost that may dilute holders - Stock Titan

Aug 26, 2026

Aug 20, 2026

Equities Analysts Offer Predictions for CRDF Q3 Earnings - MarketBeat

Aug 20, 2026

Aug 17, 2026

Enterprise value to EBIT forward of Cardiff Oncology, Inc. – DUS:XE7C - tradingview.com

Aug 17, 2026

Aug 17, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 17, 2026

Aug 14, 2026

Cardiff Oncology (CRDF) asks investors to double authorized common shares - Stock Titan

Aug 14, 2026

Aug 14, 2026

Cardiff Oncology (CRDF) Holds Near $0.98 as Consolidation PersistsFibonacci Extension - vinanet.vn

Aug 14, 2026

Aug 14, 2026

Cardiff Oncology (CRDF) Holds Near $0.98 as Consolidation PersistsOverbought Signal Alerts - careplusvn.com

Aug 14, 2026

Aug 14, 2026

Cardiff Oncology (CRDF) Holds Near $0.98 as Consolidation PersistsVolume Weighted Price - dars.gov.et

Aug 14, 2026

Aug 14, 2026

CRDF PRE 14A & SEC Filings - Yahoo Finance Australia

Aug 14, 2026

Aug 12, 2026

CARDIFF ONCOLOGY, INC. : WILLIAM BLAIR CUTS TO MARKET PERFORM RATING - webull.com

Aug 12, 2026

Aug 12, 2026

Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE) and Cardiff Oncology (CRDF) - The Globe and Mail

Aug 12, 2026

Aug 12, 2026

William Blair downgrades Cardiff Oncology (CRDF) to a Hold - The Globe and Mail

Aug 12, 2026

Aug 12, 2026

CRDF Downgraded by William Blair -- Rating Changed to Market Per - GuruFocus

Aug 12, 2026

Aug 12, 2026

William Blair Downgrades Cardiff Oncology to Market Perform From Outperform - marketscreener.com

Aug 12, 2026

Aug 12, 2026

Piper Sandler Maintains Cardiff Oncology(CRDF.US) With Buy Rating, Maintains Target Price $6 - Moomoo

Aug 12, 2026

Aug 12, 2026

William Blair downgrades Cardiff Oncology stock rating on rights uncertainty - Investing.com

Aug 12, 2026

Aug 12, 2026

William Blair downgrades Cardiff Oncology stock rating on rights uncertainty By Investing.com - Investing.com Canada

Aug 12, 2026

Aug 12, 2026

William Blair downgrades Cardiff Oncology stock rating on rights uncertainty By Investing.com - Investing.com UK

Aug 12, 2026

Aug 12, 2026

Cardiff Oncology earnings missed by $0.02, revenue topped estimates - Investing.com Canada

Aug 12, 2026

Aug 11, 2026

Cardiff Oncology earnings missed by $0.02, revenue topped estimates - Investing.com

Aug 11, 2026

Aug 11, 2026

Is Cardiff Oncology Inc (CRDF) Moving in the Right Direction Aft - GuruFocus

Aug 11, 2026

Aug 11, 2026

Cardiff Oncology: Q2 Earnings Snapshot - AOL.com

Aug 11, 2026

Aug 11, 2026

Cardiff Oncology: Q2 Earnings Snapshot - KTVB

Aug 11, 2026

Aug 11, 2026

Cardiff Oncology Q2 operating expenses fall on lower R&D costs - TradingView

Aug 11, 2026

Aug 11, 2026

Cardiff Oncology (NASDAQ:CRDF) Releases Earnings Results, Misses Expectations By $0.02 EPS - MarketBeat

Aug 11, 2026

Aug 11, 2026

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update - The Manila Times

Aug 11, 2026

Aug 11, 2026

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update - GlobeNewswire

Aug 11, 2026

Aug 11, 2026

Cardiff Oncology (NASDAQ: CRDF) cuts R&D spend but flags going concern risk - Stock Titan

Aug 11, 2026

Aug 11, 2026

Cardiff Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 11, 2026

Aug 11, 2026

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update - finance.yahoo.com

Aug 11, 2026

Aug 11, 2026

Cardiff Oncology Reports Second Quarter 2026 Results and Provides Business Update - stocktitan.net

Aug 11, 2026